Market Overview:
The global aortic and peripheral vascular interventional therapy product market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of cardiovascular diseases, technological advancements in aortic and peripheral vascular interventional therapies, and rising demand for minimally invasive procedures. Based on type, the global aortic and peripheral vascular interventional therapy product market is segmented into COP (cyclic olefin polymer), COC (cyclic olefin copolymer), and other types. The COP segment is expected to grow at the highest CAGR during the forecast period owing to its superior properties such as biocompatibility, non-toxicity, low antigenicity, good mechanical properties, and high thermal stability. Based on application, the global aortic and peripheral vascular interventional therapy product market is segmented into antithrombotics, vaccines & biologics therapies; other applications include endovascular aneurysm repair (EVAR), percutaneous transluminal angioplasty (PTA), percutaneous coronary intervention (PCI) etc.
Product Definition:
Aortic and peripheral vascular interventional therapy products are devices that are used to help treat conditions affecting the aorta and peripheral blood vessels. These products can include stents, balloons, and other medical devices that are used to open up blocked or narrowed arteries. The use of these products can help improve blood flow and reduce symptoms associated with blockages in these areas.
COP (Cyclic Olefin Polymer):
Cyclic Olefin Polymer (COP) is a kind of biodegradable polymer, which consists of carbon and hydrogen atoms in a repeated cycle. COP has the ability to absorb water and form gel-like substance inside the body. This property makes it an ideal material for medical applications such as vascular interventional therapy (VIT).
COC (Cyclic Olefin Copolymer):
COC (Cyclic Olefin Copolymer) is a kind of synthetic polymer with two different types of recurring units connected by non-reactive links. These are produced by the reaction between olefins and alcohols or amines under specific conditions.
Application Insights:
The antithrombotics segment dominated the global market in terms of revenue in 2017. This is due to a high prevalence of atrial fibrillation which results in increased demand for anticoagulants across the globe. According to data published by the CDC, around 5 million individuals are suffering from atrial fibrillation and over one-third of them are expected to develop stroke or heart attack during their lifetime. As per another study, around 54% out of total strokes that occur every year are caused by atherosclerosis which is a common precursor condition for both AF & coronary artery disease (CAD). Therefore, increasing incidences like these will boost segment growth during forecast period.
Vaccines accounted for 9% share on account of growing awareness about immunization against diseases and an increase in government initiatives towards this end globally.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of aortic stenosis and other peripheral vessels diseases, increasing adoption of minimally invasive surgeries, rising geriatric population, and government initiatives for quality healthcare services. Moreover, an increase in percutaneous transluminal coronary angioplasty procedures is further expected to drive growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving economic conditions leading to rise in disposable income levels resulting in increased demand for cardiovascular interventions along with growing target population base due to high birth rate & aging demographics which are more prone towards heart diseases & stroke respectively thus driving upmarket penetration rates of endovascular devices used for AATI procedures thereby propelling regional market growth over next eight years.
Growth Factors:
- Technological advancements in Aortic and Peripheral Vascular Interventional Therapy products that can help improve the quality of life for patients.
- Increasing incidence of aortic aneurysms and peripheral vascular diseases due to changing lifestyles and population demographics.
- Growing demand for minimally invasive procedures over traditional open surgery procedures for aortic and peripheral vascular interventions.
- Rising healthcare expenditure by governments and private players to fund Aortic and Peripheral Vascular Interventional Therapy products research & development activities as well as treatment costs.
Scope Of The Report
Report Attributes
Report Details
Report Title
Aortic and Peripheral Vascular Interventional Therapy Product Market Research Report
By Type
COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), Other
By Application
Antithrombotics, Vaccines, Biologics, Other
By Companies
BD, Gerresheimer, Nipro Corporation, Schott, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Aortic and Peripheral Vascular Interventional Therapy Product Market Report Segments:
The global Aortic and Peripheral Vascular Interventional Therapy Product market is segmented on the basis of:
Types
COP (Cyclic Olefin Polymer), COC (Cyclic Olefin Copolymer), Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antithrombotics, Vaccines, Biologics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Gerresheimer
- Nipro Corporation
- Schott
- Baxter BioPharma Solution
- Rovi CM
- Terumo
- Vetter
- Catalent
- Taisei Kako
- Roselabs Group
- West Pharma
Highlights of The Aortic and Peripheral Vascular Interventional Therapy Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- COP (Cyclic Olefin Polymer)
- COC (Cyclic Olefin Copolymer)
- Other
- By Application:
- Antithrombotics
- Vaccines
- Biologics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aortic and Peripheral Vascular Interventional Therapy Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aortic and peripheral vascular interventional therapy (IPVIT) is a medical device used to treat coronary artery disease, peripheral arterial disease, and other vascular diseases. IPVIT devices are inserted into the arteries or veins near the heart or extremities to help open blocked blood vessels.
Some of the key players operating in the aortic and peripheral vascular interventional therapy product market are BD, Gerresheimer, Nipro Corporation, Schott, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharma.
The aortic and peripheral vascular interventional therapy product market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aortic and Peripheral Vascular Interventional Therapy Product Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aortic and Peripheral Vascular Interventional Therapy Product Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aortic and Peripheral Vascular Interventional Therapy Product Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aortic and Peripheral Vascular Interventional Therapy Product Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aortic and Peripheral Vascular Interventional Therapy Product Market Size & Forecast, 2020-2028
4.5.1 Aortic and Peripheral Vascular Interventional Therapy Product Market Size and Y-o-Y Growth
4.5.2 Aortic and Peripheral Vascular Interventional Therapy Product Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 COP (Cyclic Olefin Polymer)
5.2.2 COC (Cyclic Olefin Copolymer)
5.2.3 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Antithrombotics
6.2.2 Vaccines
6.2.3 Biologics
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aortic and Peripheral Vascular Interventional Therapy Product Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aortic and Peripheral Vascular Interventional Therapy Product Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 COP (Cyclic Olefin Polymer)
9.6.2 COC (Cyclic Olefin Copolymer)
9.6.3 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Antithrombotics
9.10.2 Vaccines
9.10.3 Biologics
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 COP (Cyclic Olefin Polymer)
10.6.2 COC (Cyclic Olefin Copolymer)
10.6.3 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Antithrombotics
10.10.2 Vaccines
10.10.3 Biologics
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 COP (Cyclic Olefin Polymer)
11.6.2 COC (Cyclic Olefin Copolymer)
11.6.3 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Antithrombotics
11.10.2 Vaccines
11.10.3 Biologics
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 COP (Cyclic Olefin Polymer)
12.6.2 COC (Cyclic Olefin Copolymer)
12.6.3 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Antithrombotics
12.10.2 Vaccines
12.10.3 Biologics
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 COP (Cyclic Olefin Polymer)
13.6.2 COC (Cyclic Olefin Copolymer)
13.6.3 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Antithrombotics
13.10.2 Vaccines
13.10.3 Biologics
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aortic and Peripheral Vascular Interventional Therapy Product Market: Competitive Dashboard
14.2 Global Aortic and Peripheral Vascular Interventional Therapy Product Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Gerresheimer
14.3.3 Nipro Corporation
14.3.4 Schott
14.3.5 Baxter BioPharma Solution
14.3.6 Rovi CM
14.3.7 Terumo
14.3.8 Vetter
14.3.9 Catalent
14.3.10 Taisei Kako
14.3.11 Roselabs Group
14.3.12 West Pharma
